All Posts By

Luciana Nofal

Sanova Works SanovaWorks launches Derm In-Review

SANOVAWORKS LAUNCHES NEW DERM IN-REVIEW STUDY TOOLS

By | Derm In-Review, Residents

NEW YORK, NY (Nov. 1, 2019) – SanovaWorks launches new Derm In-Review Study Guide and Online Image Companion free for dermatology residents and dermatology professionals.

Emerging and established academic leaders from all of the various fields within dermatology have come together to redesign and update the most comprehensive study guide and online image companion in dermatology board review. Derm In-Review’s 2019/2020 study guide and online image companion match the new and pending changes to examinations that lay ahead for dermatology residents. Changes include clinical guidelines, high-def, high-quality digital images and delineation of information appropriate for the Basic, Core and Applied exams as outlined in the Exam of the Future.

Study Guide Updates

The Derm In-Review study guide is over 400 pages and formatted for quick study and easy reference. It includes call-out text, tip boxes, highlighted text, mnemonic boxes and 300+ full-color images.  The study guide is comprised of five chapters:

Chapter 1: Basic Science (including Immunodermatology)

Chapter 2: Medical Dermatology

Chapter 3: Pediatric Dermatology

Chapter 4: Surgical Dermatology

Chapter 5: Dermatopathology

Request or Download the Study Guide

2019/2020 Derm In-Review study guides will be provided to all US dermatology residents in print. A free electronic version of the study will also be available for download on the Derm In-Review website. Log in or create a complimentary account and then go to Study Guide Request in your dashboard. Special thanks goes to the Derm In-Review advertisers and corporate sponsors: Aurora Diagnostics, Celgene, Lilly, and Novartis.

In addition, all of the study guide clinical images as well as additional clinical images will be available in the Online Image Companion.  This companion includes nearly 400 original images and will allow users to log on to the website to enlarge the images for enhanced viewing.  Over 100 images are dedicated to dermatopathology board review.

Exam of the Future

The American Board of Dermatology (ABD) is restructuring the In-Training and Certification exams—moving from our current approach of emphasizing knowledge retention and visual diagnosis to exams that better emphasize the application of knowledge using clinically relevant case scenarios. The Exam of the Future will be a staged evaluation with a BASIC exam designed for first-year residents, covering dermatology fundaments; CORE exam modules testing more advanced knowledge of senior residents about dermatology’s major clinical areas; and an APPLIED exam given after residency, which tests the ability to apply knowledge in clinical situations.

Visit the Derm In-Review website for more information.  If you would like to advertise or support Derm In-Review, please reach out to Luciana Nofal at info@sanovaworks.com.  Derm In-Review is a produced and published by SanovaWorks.

 

 

MOC CertLink ODAC Dermatology

DR. STRATMAN TO PRESENT MOC CERTLINK AT ODAC

By | ODAC

NEW YORK (Oct. 30, 2019) – Erik J. Stratman, MD, 2019 President of the American Board of Dermatology (ABD), to present on Maintenance of Certification (MOC) CertLink in January at ODAC Dermatology, Aesthetic and Surgical conference.

Changes to MOC

A major shift in continuing certification is coming for board-certified dermatologists in January. Erik J. Stratman, MD will present, “Changes to Your MOC Requirements: What Every Dermatologist Should Know about CertLink,” on January 17th, 2020 at the J.W. Marriot in Orlando, Florida.

Workshop Description

Dr. Stratman will walk-through the CertLink® MOC program and demonstrate its design, rationale and navigation. According to the ABD, CertLink provides the utmost flexibility in MOC and provides an alternative to the one-time, sit-down, high stakes in-person MOC examination. Dermatologists will be able to go online and take test questions in the convenience of their own home or office at various times throughout the year.

ABD MOC CertLink®

CertLink® is a longitudinal testing platform. The platform is designed to test and build medical knowledge in a “test to competence” type model.  In addition, CertLink® will keep dermatologists up to date by providing the latest articles from dermatology subspecialties. CertLink™ assessment platform is powered by American Board of Medical Specialties (ABMS).

Registration and Fees

The pre-conference workshop is provided complimentary for dermatologists registered for ODAC 2020.

About ODAC

Attend ODAC to stay connected, informed, and up-to-date in dermatology. ODAC (previously Orlando Derm) is one of the largest and most prestigious conferences of the year. ODAC attracts a national audience of over 650 US Dermatology Physicians, Dermatology Residents, Nurse Practitioners and Physician Assistants.

Visit orlandoderm.org to register for ODAC and attend this workshop.  ODAC is a product of SanovaWorks.

 

 

ODAC Dermatology Sold Out Hot Topics

ODAC OFFERS MORE ACCESS TO HOT TOPICS

By | ODAC, Press

New York (Oct. 28, 2019) – The ODAC Dermatology, Aesthetic & Surgical Conference (ODAC) is extending its program for 2020 with additional time for ODAC hot topics, general sessions and workshops.

Attendee Feedback

“We’ve listened to our attendees and altered our program to provide greater access to the hottest topics in the field,” said Perry Robins, MD, dermatologist and founder of ODAC. “Our sessions are led by expert faculty who provide the latest research and clinical updates on a variety of medical, surgical and aesthetic dermatology topics.”

The 2020 conference will be held January 17-20 at the JW Marriott in Orlando, Florida. ODAC, which started in 2003, attracts more than 650 dermatology physicians, residents, nurse practitioners and physician assistants each year.

The 2020 conference focuses on clinical dermatology updates, new treatments, new uses for old treatments, new product lines, changes to therapeutic guidelines, and hot and controversial topics. The interactive learning experience includes more than 20 workshops and more than 5 hours of live aesthetic demonstrations. In addition, ODAC offers hands-on sessions, live Q&As and opportunities to dialogue with leaders in the field. Up to 31 AMA PRA Category 1 Credits™ are available.

One-of-a-Kind

“There is no other conference like ODAC,” said dermatologist and conference chair James Spencer, MD, MS. “Each presentation provides practical pearls you can implement in your practice. This will be my 17th ODAC, and this meeting keeps getting better and better.”

In addition, three pre-conference workshops are available the first day of the conference:

  • “Comprehensive Nonsurgical Aesthetic Rejuvenation” with Martin Braun, MD
  • “Maintenance of Certification Workshop (Self-Assessment Credit)” with Erik Stratman, MD
  • “Derm In-Review Board Review” with session chair and conference medical director Adam Friedman, MD (in partnership with George Washington University)

Additional Faculty

  • Joel L. Cohen, MD, vice conference chair
  • Susan H. Weinkle, MD, vice conference chair
  • Martin Braun, MD
  • Justin Finch, MD
  • Robert Gotkin, MD
  • Jeremy Green, MD
  • William Hanke, MD
  • John Harris, MD
  • Sima Jain, MD
  • Terrence Keaney, MD
  • Leon Kircik, MD
  • Yasmine Kirkorian, MD
  • Sailesh Konda, MD
  • Angelo Landriscina, MD
  • Kavita Mariwalla, MD
  • Amy McMichael, MD
  • Alan Menter, MD
  • David Miller, MD
  • Vishal Patel, MD
  • Desiree Ratner, MD
  • Victor Ross, MD
  • Deborah S. Sarnoff, MD
  • Linda Stein Gold, MD
  • Erik Stratman, MD
  • Jackie Yee, MD
  • Jonathan Zippin, MD

Attendees may visit the exhibit hall that showcases the latest innovations in dermatology by more than 70 companies. In addition, more than 80 research and case study posters are available for viewing. The Advanced Resident Training and Education (ARTE) scholarship program provides the ODAC learning experience to more than 100 future dermatologists.

ODAC is a product of SanovaWorks, publisher of the Journal of Drugs in Dermatology (JDD) and producer of the Skin of Color Update conference.

Registration is available at orlandoderm.org.

Skin of Color Update Press Coverage

SKIN OF COLOR UPDATE 2019 COVERAGE

By | Press, Skin of Color, Skin of Color Update

NEW YORK (Oct. 15, 2019) Skin of Color Update 2019 continues to receive coverage from various media outlets after producing a sold out event.  A SanovaLive event, Skin of Color Update, Sept. 7 & 8, 2019 at the Crowne Plaza Times Square hosted an expert faculty with 2 days education, networking and discovery.  This 2-day event attracted over 300 dermatology providers from all over the US. Missed the event? Purchase it on-demand here.

See what the media has to say about the event and register for Skin of Color Update 2020 before it sells out.

The Dermatologist covered Wendy Roberts, MD session on Hair and Scalp Disorders: A Review of Alternative Therapies


In an interview with The Dermatologist, Skin of Color Update presenter Cheryl M. Burgess, MD, discusses  her lecture on common cosmetic concerns among patients with skin of color and the importance of recognizing adverse reactions.


Sun protection in Skin of Color patients still matters. Find out what Henry Lim, MD had to say in an interview with The Dermatologist regarding his lecture at Skin of Color Update 2019.  Read more.


Skin of Color Update speaker Theodore Rosen, MD presented on hidradenitis suppurativa in the black community and the improvement of disease control.  Read an overview of his session here.


Andrew Alexis, MD presented clinical findings on new drugs that particularly benefit skin of color patients with acne. Read the overview on Dermatology News.


Skin of color poses some unique challenges when it comes to diagnosing atopic dermatitis (AD). In a recent interview, co-founder and co-chair Andrew Alexis, MD discusses his challenges and pearls for treating AD in skin of color.  Read more.


Dermatology News recently covered Wendy Roberts, MD Skin of Color Update 2019 presentation on combination treatments for pseudofolliculitis barbae.  Read the interview and more here.


Whitening of skin remained charged topic at the recent Skin of Color Update, co-founder and co-chair Eliot F. Battle, Jr. MD lead the discussion with an interesting expert opinion on the topic.  Read more.


Register for Skin of Color Update at the Sheridan Times Square, September 12 and 13, 2020.

Purchase Skin of Color Update On-Demand:

Skin of Color Update Dermatology On-Demand

ODAC 2020 ARTE Dermatology Resident Scholarships

DERMATOLOGY RESIDENT SCHOLARSHIPS FOR ODAC 2020

By | ODAC, Residents

ORLANDO (updated Oct.16, 2019) ODAC Dermatology, Aesthetic and Surgical (ODAC) conference announced the first round of dermatology resident scholarships for the January 17 – 20, 2020 meeting at the JW Marriott, Orlando, Florida.

ODAC has awarded over 3,000 dermatology resident scholarships over 16 years, and is hailed the #1 and largest scholarship program for dermatology meetings.

Each year, nearly 900 dermatologists and allied health professionals attend ODAC making it one of the largest medical, aesthetic and surgical dermatology conferences in the United States.  Of the 900 attendees, ODAC hosts over 150 US dermatology residents as part of the Advanced Resident Training Education (ARTE) Scholarship program.

Dermatology residents attending ODAC have the opportunity to be paired one-on-one with a mentor, publish with media partners, and present an abstract in the Annual ARTE Scholar Poster Session.  ODAC offers content specifically designed for the dermatologist-in-training including:

  • Dermatology In-Review Board Review Session hosted in conjunction with George Washington University
  • Resident Program Track with specific talks and workshops of most relevance for the resident attendee
  • 17th Annual Hands-On Aesthetic Training Workshop
  • 10th Annual Resident ARTE Scholar Poster Competition
  • Pair one-on-one with an expert mentor in the dermatology field
  • Publish in Next Steps in Derm

From July to October 18th, ODAC accepts over 500 scholarship applications from dermatology residents training at over 160 US Dermatology Residency programs for MD and DO.  Resident applicants submit their C.V., a letter of good standing for their residency and compete with other program residents for the coveted scholarship positions.

On behalf of SanovaWorks,  we would like to congrats the first and second round of ARTE Scholar Awardees:

Blair Saunders Allais MD
Kathryn Lee Anderson MD
Brandon Michael Basehore DO
Cassandra Beard DO
Lisa Bedford MD
Hamza Dastgir Bhatti DO
Nathan Bibliowicz DO
Nikoleta Brankov MD
Margaret E Brown MD
Soham Chaudhari DO
Judy Cheng MD
Hassie Cooper DO
Megan Cronin MD
George Olen Denny MD, MS
Shannon Quirk Detty MD
Ashley Marie Dietrich MD
Andrew Spiros Dorizas MD
Andrew Colin Duncanson DO
Misty Eleryan MD, MS
Amarachi Chioma Eseonu MD
Jessica Feig MD PhD
Aaron Yeu Wah Fong MD
Fabrizio (Marina) Galimberti MD PhD
Zachary Gillooly MD
Sibel Gokce MD
Alexandra Grammenos DO
Anna Gregoire MD
Erica Ann Grilletta M.D.
Christopher Haley M.D.
Ingrid Herskovitz MD
Angela Hou MD
Gabriel Isaza-Gonzalez MD
Reshmi Kapoor MD
Genevieve York Kaunitz MD
Trisha Khanna md
Raymond Kleinfelder DO
Steven Krueger MD
Olivia Yu-Ping Lai MD
Yi Chun Lai MD, MPH
Krista Larson MD
Danielle Raffaella Lazzara DO
Ming Hua Lee MD
Yumeng Li MD MS
Xiaoxiao Li MD, PhD
Sarah Lonowski MD, MBA
Jason Mammino DO
Eric Maranda MD
Samantha Alexa Marrone MD
Jacqueline McKesey MD, MS
John Richard Moesch DO
Tasneem Mohammad MD
Tejaswi V Mudigonda MD
Robert D Murgia DO
Nicole Negbenebor MD
Kevin Nethers MD
Sarah Nichols MD
Timothy Nyckowski D.O.
Amit Om MD
Jigar Patel MD
Manoj Karbhari Pawar MD
Quy Pham MD
Ji Qi MD
Saleh Rachidi MD, PhD
Asmi Sanghvi DO
William Schaffenburg MD
Gene Schwartz MD
Mehreen Joy Sheikh DO
Betty Song MD
Olivera Stojadinovic MD
Shalini Thareja MD
Rebecca Stoner Thornhill MD
Jeffrey Wargo MD
Brooke Wehausen DO
Allison Weinkle MD
Annie Wester MD
Kiyanna Williams MD
Aubrey Elizabeth Winn MD
Yi Yang MD
Mina Zarei MD
Myron Zhang MD
Patrick Zito DO, PharmD

There is still time to apply! ODAC is accepting applications until October 18, 2019.  Apply now.

 

About ODAC

ODAC is the premier clinical dermatology conference expertly curated to provide comprehensive, annual updates and fresh pearls in medical, aesthetic and surgical dermatology.  The ODAC dermatology conference focuses on new uses for old treatments, incorporating new treatments, products and treatment lines, critical updates in diagnosis guidelines, as well as advanced techniques for enhancing your surgical and nonsurgical patient outcomes.

 

 

 

 

 

 

 

ndrew Alexis receiving JDD award for Innovations in Dermatology from Skin of Color Update

ANDREW F. ALEXIS, MD, MPH, PRESENTED WITH INNOVATIONS AWARD

By | Press

NEW YORK (Sept. 9, 2019) – The Journal of Drugs in Dermatology (JDD) presented dermatologist Andrew F. Alexis, MD, MPH, with the Innovations in Skin of Color Dermatology Award at Skin of Color Update, formerly Skin of Color Seminar Series, held September 7 and 8 in New York. The award recognizes individuals who have fostered innovation and improvement in dermatology through increased emphasis on skin of color education and research. If you missed the event, you can purchase lectures on-demand here.

“Andrew F. Alexis, MD, MPH is committed and passionate — not only about being the best dermatologist he can be – but also about bringing skin of color education to dermatology,” said Shelley Tanner, CEO and president of SanovaWorks, which produces the JDD and Skin of Color Update. “Through his efforts, the changing landscape of patients can now thrive through treatment and management plans that address their specific needs.”

“Dr. Alexis is the top innovator in the dermatologic and cosmetic treatment of patients with skin of color,” said dermatologist Eliot F. Battle, MD, co-chair of Skin of Color Update along with Dr. Alexis. “His decades of pioneering research in dermatology have led to the development of new procedures and products that address a wide range of dermatologic conditions. He compassionately treats his patients, shares his expertise by presenting throughout the world and gives back through mentoring the next generation of dermatologists and researchers. I am honored to serve alongside this distinguished innovator.”

Dr. Alexis is chair of the department of dermatology and director of the Skin of Color Center at Mount Sinai St. Luke’s and Mount Sinai West, New York. As such, he is actively involved in advancing patient care, research and education pertaining to dermatologic disorders that are prevalent in ethnic skin. He is also professor of dermatology at the Icahn School of Medicine at Mount Sinai.

Dr. Alexis received his medical degree from Columbia University College of Physicians & Surgeons and his Master of Public Health at Columbia University’s Mailman School of Public Health. He completed his dermatology residency at Weill Cornell Medical Center, followed by a fellowship in dermatopharmacology at New York University School of Medicine.

Dr. Alexis has published more than 70 articles in peer-reviewed journals and has co-edited two text books on dermatology for skin of color as well as authored 10 book chapters. He is a past president of the New York Dermatological Society and is currently chair of the Scientific Committee of the Skin of Color Society.

The recipient of the Innovations in Skin of Color Dermatology Award, given by the Journal of Drugs in Dermatology, is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology practitioners and several industry leaders.

The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by dermatologist Perry Robins, MD. Now in its 18th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports and timely features pertaining to new methods, techniques and drug therapy that provide readers with peer-reviewed content of the utmost quality. The JDD is overseen by an International Editorial Board of more than 160 renowned experts and reaches more than 30,000 dermatology healthcare practitioners worldwide.

Skin of Color Update 2020 will be held September 12th – 13th at the Sheraton Times Square.

Media Contact:
Allison Sit
allison.sit@gmail.com

Purchase Skin of Color Update On-Demand: 

Skin of Color Update Dermatology On-Demand

Adam Friedman at ODAC

GW RESEARCHERS IDENTIFY BARRIER TO FUNGAL INFECTION DIAGNOSIS

By | Press

In a recent survey, researchers identified the barriers to accurately diagnosing cutaneous fungal infections

August 8, 2019

WASHINGTON (Aug. 8, 2019) —There are several barriers that prevent the consistent use of fungal diagnostic preparations to correctly identify cutaneous fungal infections, according to a survey from a team at the George Washington University (GW). The study is published in the Journal of Drugs in Dermatology.

Cutaneous fungal infections account for between 3.5 and 6.5 million dermatologist office visits per year. Despite their frequency, the diverse presentations of fungal infections often lead to misdiagnosis, resulting in additional costs, time, and delays in proper care. Direct microscopy using potassium hydroxide (KOH) or other stains provides an inexpensive method to diagnose fungal infections. However, this requires clinics to have the Clinical Laboratory Improvement Amendment (CLIA) certification.

“Because of the extraordinary ability for these fungal infections to mimic other skin diseases, identification based on clinical inspection alone can often lead to misdiagnosis and mismanagement,” said Adam Friedman, MD, professor and interim chair of the Department of Dermatology at the GW School of Medicine and Health Sciences and senior author on the study. “Little is known regarding the frequency with which dermatologists use these simple, yet diagnosis changing bedside fungal preparations, nor do we know if and what barriers exist preventing accurate diagnosis of infections.”

Friedman’s team previously published research highlighting the difficulty even dermatologists have when distinguishing between skin fungal infections and other inflammatory skin diseases, highlighting the importance of using laboratory-based tools to aid in patient care.

This survey, led by Emily Murphy, a research fellow in the Department of Dermatology at the GW School of Medicine and Health Sciences, was distributed via email to participants of the ODAC Dermatology Aesthetic and Surgical Conference, and the data was compiled in a web-based platform. Of the respondents, around 21% indicated they rarely/never perform fungal preparations and about 20% reported they sometimes do, often because they think clinical diagnosis is adequate or because fungal preparations take too long. Additionally, about 21% of respondents reported not having CLIA certifications, mostly because the process requires too much work or because they do not know how to apply. Of the providers who have CLIA certification, more than 25% reported that it was difficult to obtain.

“Our results indicate the need for increased education about the many clinical faces of cutaneous fungal infections and proper use of bedside diagnostics,” Friedman said. “It also highlights the need for policy-based interventions in order to ease the process of CLIA certification, to ensure that dermatology clinics are equipped to accurately diagnose infections.”

The study, titled “Use of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections,” published in the Journal of Drugs in Dermatology can be found at jddonline.com/articles/dermatology/S1545961619P0798X/1/.

Media: For more information or to set up an interview, please contact Ashley Rizzardo at amrizz713@gwu.edu or 202-994-8679.

###

About the GW School of Medicine and Health Sciences
Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation’s capital and is the 11th oldest in the country. Working together in our nation’s capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. smhs.gwu.edu

All new JDDonline.com

NEWLY REDESIGNED JDDONLINE PROVIDES FASTER, MORE USER-FRIENDLY

By | Press

NEWLY REDESIGNED JDDONLINE PROVIDES FASTER, MORE USER-FRIENDLY

ACCESS TO THE JOURNAL OF DRUGS IN DERMATOLOGY

New York (June 18, 2019)– The Journal of Drugs in Dermatology (JDD) has a newly revamped website, JDDonline.com, which offers a fully-responsive design for more user-friendly browsing. With updated navigation, seamless transition from desktop to mobile viewing and new search features, subscribers are able to access JDD content, renew their subscriptions and view multimedia faster and easier than ever before.

“Our goal is to get the latest dermatologic research into the hands of clinicians as quickly and easily as possible so that the latest advancements can be further researched and implemented,” said Shelley Tanner, CEO and president of SanovaWorks, parent company of the JDD.

The redesigned site makes it easier to navigate the journal’s award-winning content, including multimedia, such as the JDD Podcastand Translational Lecture Series. In addition, subscribers can view PDFs of articles and archived issues.

The journal has also launched a new manuscript submission and peer-review site. The updated, streamlined submission process facilitates compliance with publishing requirements and allows fast, easy upload of manuscript files, figures and materials. The manuscript submission site can be accessed from JDDonline.comby clicking on the Authors tab at the top of the page or by visiting the site directly at jdd.msubmit.net.

“The manuscript submission process is easy to follow, which ensures completeness, quality control and timely submission,” Tanner said. “From the submission process to the final product, the Journal of Drugs in Dermatologystrives to be the leader in dermatologic publishing.”

The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by dermatologist Perry Robins, MD. Now in its 18th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports and timely features pertaining to new methods, techniques and drug therapy that provide readers with peer-reviewed content of the utmost quality. The JDD is overseen by an International Editorial Board of more than 160 renowned experts and reaches more than 30,000 dermatology healthcare practitioners worldwide.

 

Media Contact:

Allison Sit

allison.sit@gmail.com

Burt's Bees and Dermatology Journal of Drugs in Dermatology study

JDD PUBLISHES STUDY ON CLINICAL IMPROVEMENTS WITH BURT’S BEES’ SENSITIVE SKIN REGIMEN AS ADJUNCT TO ROSACEA THERAPY

By | Press

Journal of Drugs in Dermatology Publishes Study Showcasing Clinical Improvements with Burt’s Bees’ Sensitive Skin Regimen as Adjunct to Rosacea Prescription Therapy

Data Demonstrating Regimen’s Outperformance of a Dermatologist-Recommended Control to be presented at American Academy of Dermatology Annual Meeting

DURHAM, N.C.–(BUSINESS WIRE)–Burt’s Bees, a leading provider of personal care products committed to natural health and beauty solutions, today announced that the Journal of Drugs in Dermatology has published clinical data supporting the efficacy and tolerability of Burt’s Bees skin care products as an adjunct to rosacea prescription therapy. Abstracts outlining the study data will be shared at the American Academy of Dermatology Annual Meeting on March 1-5, 2019, in Washington, D.C.

For access to the manuscript click here.

Click here to read the complete press release.

Dr. Alan Menter at ODAC Award from JDD

ALAN MENTER, MD, HONORED BY ODAC AND THE JOURNAL OF DRUGS IN DERMATOLOGY

By | Press

ALAN MENTER, MD, HONORED BY ODAC AND THE JOURNAL OF DRUGS IN DERMATOLOGY

ORLANDO, Fla. (Jan. 22, 2019) – The ODAC Dermatology, Aesthetics & Surgical Conference, in partnership with the Journal of Drugs in Dermatology (JDD), honored dermatologist Alan Menter, MD, with the Outstanding Researcher & Educator in Psoriatic Disease Award at the conference held January 18-21 in Orlando, Fla. The award recognizes Dr. Menter’s significant contribution and lifetime commitment to the advancement of psoriatic disease research as well as his work guiding the next generation of psoriasis experts and researchers.

“Dr. Menter has dedicated his career to improving psoriasis treatment options and standards of care while also pouring countless hours into up-and-coming psoriasis experts and researchers, ensuring his legacy will continue for generations to come,” said Shelley Tanner, CEO and president of SanovaWorks, which produces the JDD and ODAC.

Bobby Mansouri, MD, became a dermatologist after serving as a research fellow under Dr. Menter and, as such, gives testimony to Dr. Menter’s impact on dermatologists and their patients.

“Dr. Menter has led the way as a champion for psoriatic disease,” said Dr. Mansouri. “It is because of people like Dr. Menter that the newest generation of dermatologists will thankfully never know the full struggle of managing psoriatic patients without targeted therapies. His dedication to psoriasis and research is one of the major reasons thousands upon thousands of patients finally have their psoriasis controlled.”

Dr. Menter is the chair of the Department of Dermatology and director of the Dermatology Residency program at Baylor University Medical Center in Dallas. In 2018, he was awarded Top Dermatologist of the Year by the International Association of Top Professionals, and in 2013, he received the Lifetime Achievement Award from the National Psoriasis Foundation. He founded the International Psoriasis Council in 2003. Dr. Menter is currently co-chair of the American Academy of Dermatology Psoriasis Guideline Work Group. He has served as an ODAC faculty member for two consecutive years.

The recipient of the Outstanding Researcher & Educator in Psoriatic Disease Award, given by the Journal of Drugs in Dermatology, is nominated and chosen through the recommendation of a panel of senior national thought-leaders in dermatology, a committee of dermatology practitioners and several industry leaders. The Journal of Drugs in Dermatology (JDD), a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®, was founded by dermatologist Perry Robins, MD. Now in its 18th year, it offers one of the fastest routes to disseminate dermatologic information, and is considered the fastest growing publication in dermatology, presenting original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology, which provide readers with peer-reviewed content of the utmost quality. The JDD is overseen by an International Editorial Board of more than 160 renowned experts and reaches more than 30,000 dermatology healthcare practitioners worldwide.

###